Phase 2 Ovarian Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

• People who have given written informed consent before any study-related procedures begin.
• Women aged 20 years or older.
• People with a general health/activity level rated as 0, 1, or 2 on a standard oncology scale (meaning able to carry out at least some daily activities — confirm with trial site).
• People with a life expectancy of at least 3 months.
• People who are able to follow the trial's requirements and schedule.
• People who have been confirmed through a tissue sample to have high-risk ovarian cancer at an advanced stage (Stage III or IV, using international gynaecology guidelines), and who have achieved a complete remission (no detectable cancer) after treatment for their first recurrence.
• People who are not pregnant, and who are using appropriate contraception if there is any possibility of becoming pregnant.
• People whose blood test results show healthy bone marrow function, with sufficient white blood cell and platelet counts.
• People whose blood test results show that the kidneys and liver are functioning within acceptable levels.

Who may not be able to join:

• People whose ovarian cancer is of a non-epithelial type (a specific tissue type — confirm with trial site).
• People with ovarian tumours classified as borderline (low malignant potential).
• People who have both endometrial cancer and ovarian cancer occurring at the same time.
• People with signs of free air in the abdomen that cannot be explained by a recent medical procedure.
• People who have previously received gene-engineered T cell therapy (a type of immune cell treatment — confirm with trial site).
• People who are currently taking, or have recently taken (within 28 days before the trial start), another experimental drug, or who have previously participated in this same trial.
• People who have had a minor surgical procedure within 2 days before the trial start date, including procedures such as placement of a central line, tumour biopsy, or needle fluid sampling.
• People who are pregnant or currently breastfeeding.
• People whose blood test results show bone marrow function that falls below the required levels for white blood cells, platelets, or haemoglobin.
• People whose blood test results show liver or kidney function below the required levels, including certain markers of liver health, kidney filtering ability, or protein in the urine above acceptable limits.
• People who have a serious active infection currently requiring intravenous (IV) antibiotics.
• People who test positive for HIV, syphilis (Treponema pallidum), or active tuberculosis.

Important: Always verify eligibility with the trial site directly before applying."